1. Home
  2. GH vs GBCI Comparison

GH vs GBCI Comparison

Compare GH & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$103.60

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Glacier Bancorp Inc.

GBCI

Glacier Bancorp Inc.

HOLD

Current Price

$42.59

Market Cap

5.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
GBCI
Founded
2011
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.6B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GH
GBCI
Price
$103.60
$42.59
Analyst Decision
Strong Buy
Buy
Analyst Count
21
5
Target Price
$79.19
$51.80
AVG Volume (30 Days)
2.9M
715.8K
Earning Date
10-29-2025
01-22-2026
Dividend Yield
N/A
3.07%
EPS Growth
N/A
26.70
EPS
N/A
2.05
Revenue
$902,569,000.00
$900,148,000.00
Revenue This Year
$34.72
$13.46
Revenue Next Year
$26.46
$27.84
P/E Ratio
N/A
$20.94
Revenue Growth
30.38
15.35
52 Week Low
$29.91
$36.76
52 Week High
$112.43
$58.54

Technical Indicators

Market Signals
Indicator
GH
GBCI
Relative Strength Index (RSI) 66.40 51.25
Support Level $98.23 $41.93
Resistance Level $112.43 $43.38
Average True Range (ATR) 5.44 1.24
MACD -0.54 0.35
Stochastic Oscillator 64.46 78.09

Price Performance

Historical Comparison
GH
GBCI

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About GBCI Glacier Bancorp Inc.

Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.

Share on Social Networks: